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AbsTRACT
background: Studies of acetaminophen suggest that multiple nociceptive 
pathways are involved in the drug’s analgesic action.
Objective: The purpose of this study was to determine whether naloxone and 
flumazenil were able to modify or antagonize the antinociceptive effect of acetamino-
phen in rats.
Methods: Adult albino Wistar rats were used in the study and randomly allo-
cated to 1 of 4 groups. The acetaminophen group (A group) was administered IP saline 
and then 300 mg/kg IP acetaminophen 5 minutes thereafter. The acetaminophen + 
naloxone group (AN group) was pretreated with 1 mg/kg IP naloxone, followed 
by 300 mg/kg IP acetaminophen 5 minutes later. The acetaminophen + flumazenil 
group (AF group) was pretreated with 1 mg/kg IP flumazenil, followed by 300 mg/kg 
IP acetaminophen 5 minutes later. The control group received 2.5 mL IP saline, followed 
by an additional 2.5 mL IP injection of saline 5 minutes later. The paw-withdrawal la-
tency period of the rats was assessed by an investigator blinded to treatment using the 
hot-plate test at 30, 45, 60, and 90 minutes after administration of acetaminophen.
Results: Thirty-two rats were evenly randomized by envelope method into 
4 groups of 8 rats each. Baseline values for the A, AN, AF, and control groups were 
not significantly different (9.1 [2.3], 10.5 [2.7], 9.8 [3.0], and 8.9 [1.4] sec, respec-
tively). In the AF group, flumazenil appeared to antagonize the analgesic effect 
exerted by the acetaminophen in the hot-plate test (30 min, 10.3 [3.7] sec; 45 min, 
11.7 [5.1] sec; 60 min, 12.1 [5.1] sec; and 90 min, 12.2 [4.9] sec) and values were 
not significantly different from those obtained in the control group (30 min, 9.8 [2.2] sec; 
45 min, 9.0 [1.6] sec; 60 min, 9.2 [1.6] sec; and 90 min, 8.5 [2.0] sec). In the AN group, 
naloxone did not significantly affect the values observed in the hot-plate test (30 min, 
18.0 [4.5] sec; 45 min, 21.5 [7.8] sec; 60 min, 20.5 [5.9] sec; and 90 min, 22.3 [7.4] sec) 
and values at all time points were not significantly different from those obtained in the 
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A group (30 min, 17.8 [7.6] sec; 45 min, 20.9 [6.9] sec; 60 min, 21.5 [7.3] sec; and 
90 min, 23.8 [8.6] sec). All postbaseline values in the A and AN groups were signifi-
cantly increased versus baseline and versus the control group values (all, P < 0.05). 
All postbaseline values in the A group were significantly greater than those in the 
AF group (all, P < 0.05).
Conclusion: Flumazenil antagonized the analgesic effect exerted by aceta-
minophen, while naloxone had no significant effect on acetaminophen’s antinocicep-
tive action in this pain model in rats. (Curr Ther Res Clin Exp. 2010;71:111–117) 
© 2010 Excerpta Medica Inc.
Key words: antinociceptive action, acetaminophen (paracetamol), flumazenil, 
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InTROduCTIOn
Acetaminophen’s mechanism of action is primarily believed to be via central cyclooxy-
genase inhibition.1 Studies designed to prove the antinociceptive action mechanism 
of acetaminophen have suggested that multiple nociceptive pathways may be involved 
in the analgesic action.1–5 
Gamma-aminobutyric acid (GABA) is a significant inhibitor neurotransmitter in the 
central nervous system.6 GABA receptors are located at both peripheral and central sites 
and, in particular, they are present in the dorsal horn of the spinal cord.7 GABA receptors 
act by means of adhesion to chloride channels located in subsynaptic membranes in the 
spinal system, generating a GABA receptor-chloride channel complex. GABA receptor 
agonists create a conformational difference in the chloride channels.6
Based on pharmacologic experiments, 3 types of opioid receptors were postulated. 
They were named μ for morphine type, κ for the ketocyclazocine type, and σ for the 
SKF10047 (N-allylnormetazocine) type. In addition, a high-affinity receptor for 
enkephalins found in the mouse was deferens, and named as a delta (δ) receptor.8 
Flumazenil, as a derivate of 1,4-imidazodiazepine, is an antagonist of benzodiaz-
epines with partial agonist properties.6 Benzodiazepine receptors are associated with 
pain transmission in the dorsal horn of the spinal cord.9 Flumazenil has been reported 
to reverse all of the dose-related effects of benzodiazepines (anticonvulsive, sedative, 
anxiolytic, myorelaxant, and amnesic).6 It acts by means of competitive adherence to syn-
aptic GABA receptors. However, it does not have any effects on peripheral GABA’ergic 
(renal, cardiac, hepatic, testicular, adrenal, etc) receptors.10
Naloxone is a semisynthetic opioid competitive antagonist. Naloxone antagonizes 
the analgesic actions as well as the other effects of morphine such as respiratory de-
pression by means of binding to the μ, δ, κ, and σ central receptors of morphine and 
similar analgesics.8,11
This study was conducted to gain insight into the mechanism of the analgesic ac-
tion of acetaminophen and the influences of naloxone and flumazenil on this action. 
Accordingly, the purpose of this study was to find out whether naloxone and fluma-
zenil were able to modify or prevent the antinociceptive effect of acetaminophen in 
the hot-plate test in rats.
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MATeRIAls And MeTHOds
experiment Animals
This study was performed in adult albino Wistar rats at the Experimental and 
Clinical Research Center of Erciyes University Medical Faculty, Kayseri, Turkey. The 
ethical guidelines for investigation of experimental pain in conscious animals were 
followed in all tests, and the procedures were carried out according to the EEC ethical 
regulations for animal research (European Economic Community council 86/609; 
D.L. 27/01/1992, No. 116). The rats were housed in plastic cages, 8 per cage, with 
free access to rat food (Aytekinler, Konya, Turkey) and tap water, and maintained on 
a 12-hour dark/light cycle (light on at 7:00 am) under controlled environmental con-
ditions (temperature, 20°C; humidity, 40%–50%).
Hot-Plate Test
The rats that were used in the experiment were randomly assigned by envelope 
method to 1 of 4 groups. The hot plate consisted of an electrically heated surface with 
temperature readout kept at a constant temperature of 52°C and double checked with 
surface measurements. “Cut-off time” was adjusted to 40 seconds. The latencies for 
paw withdrawal (or jumping) of the rats were assessed with the hot-plate test at 30, 
45, 60, and 90 minutes after acetaminophen administration by the same investigator 
blinded to the treatment groups. To ensure blinding, the investigator who assessed paw 
withdrawal latency was different from the investigator who administered treatment.
experiment Groups and drug doses used
All administration of medication and normal saline was conducted intraperitone-
ally. Rats in the acetaminophen group (group A) were administered IP saline followed 
by 300 mg/kg IP acetaminophen* 5 minutes thereafter. In the acetaminophen + 
naloxone group (group AN), pretreatment with 1 mg/kg IP naloxone (1 mg/mL; 
Sigma-Aldrich, St. Louis, Missouri) was followed by 300 mg/kg of acetaminophen 
5 minutes later. The acetaminophen + flumazenil group (group AF) was pretreated 
with 1 mg/kg IP flumazenil† (0.5 mg/5 mL) followed by 300 mg/kg IP acetaminophen 
5 minutes later. The control group was administered 2.5 mL IP saline followed by a 
second administration of 2.5 mL saline 5 minutes later.
statistical Analysis
Statistical analysis of the study was performed using SPSS software version 15.0 
(SPSS Inc., Chicago, Illinois). The primary end point of the study was paw with- 
drawal latency. The obtained data was reported as mean (SD). A 1-way ANOVA was 
performed for between-group comparisons. Statistical significance was determined by 
Tukey test. Repeated measures ANOVA test was performed for in-group comparisons. 
P < 0.05 was considered statistically significant.
*Trademark: Perfalgan® (Bristol-Myers Squibb, Rueil Malmaison, France).
†Trademark: Anexate® (Roche Products, Basel, Switzerland).
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ResulTs
Thirty two rats (weight range, 210–250 g) were evenly allocated to 4 groups of 8 rats 
each. Baseline values for the A, AN, AF, and control groups were not significantly 
different (9.1 [2.3], 10.5 [2.7], 9.8 [3.0], and 8.9 [1.4] sec, respectively) (Table). In the 
AF group, flumazenil appeared to antagonize the analgesic effect exerted by the ace-
taminophen in the hot-plate test (30 min, 10.3 [3.7] sec; 45 min, 11.7 [5.1] sec; 60 min, 
12.1 [5.1] sec; and 90 min, 12.2 [4.9] sec) and values were not significantly different 
from those obtained in the control group (30 min, 9.8 [2.2] sec; 45 min, 9.0 [1.6] sec; 
60 min, 9.2 [1.6] sec; and 90 min, 8.5 [2.0] sec). In the AN group, naloxone did not 
significantly affect the values observed in the hot-plate test (30 min, 18.0 [4.5] sec; 
45 min, 21.5 [7.8] sec; 60 min, 20.5 [5.9] sec; and 90 min, 22.3 [7.4] sec) and values 
at all time points were not significantly different from those obtained in the A group 
(30 min, 17.8 [7.6]; 45 min, 20.9 [6.9]; 60 min, 21.5 [7.3]; and 90 min, 23.8 [8.6] sec). 
All postbaseline values in the A and AN groups were significantly increased versus 
baseline and versus the control group values (all, P < 0.05). All postbaseline values in 
the A group were significantly greater than those in the AF group (all, P < 0.05).
Table.  Paw latency period in a hot-plate test in rats administered acetaminophen (A), 
acetaminophen + naloxone (AN), acetaminophen + flumazenil (AF), or saline (con-
trol) (N = 32). Data are mean (SD) seconds.*
Time, min
Group A 
(n = 8)
Group AN 
(n = 8)
Group AF 
(n = 8)
Control Group 
(n = 8)
Baseline 9.1 (2.3) 10.5 (2.7) 9.8 (3.0) 8.9 (1.4)
30 17.8 (7.6)
(0.019)†
(0.03)‡
18.0 (4.5)
(0.008)†
(0.016)‡
10.3 (3.7)
(0.045)§
9.8 (2.2)
45 20.9 (6.9)
(0.001)† 
(0.002)‡
21.5 (7.8) 
(0.01)†
(0.001)‡
11.7 (5.1) 
(0.02)§
9.0 (1.6)
60 21.5 (7.3) 
(0.001)†
(0.001)‡
20.5 (5.9) 
(0.004)†
(0.002)‡
12.1 (5.1)
(0.01)§
9.2 (1.6)
90 23.8 (8.6) 
(0.002)†
(<0.001)‡
22.3 (7.4) 
(0.003)†
(0.001)‡
12.2 (4.9) 
(0.005)§
8.5 (2.0)
* There were no statistically significant differences between the AF and control groups; there were no 
statistically significant differences between the A and AN groups.
†  Versus baseline.
‡  Versus the control group.
§  Versus the A group.
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dIsCussIOn
Studies suggest that acetaminophen may have multiple mechanisms of antinociceptive 
action.1,12,13 The present study suggests that the antinociceptive action of acetamino-
phen is antagonized by the benzodiazepine-GABA receptor antagonist, flumazenil.
It has been reported that the antinociceptive action of high- (400 mg/kg) and low-
dose (100 mg/kg) acetaminophen is antagonized by naloxone, which is a nonselective 
opioid receptor antagonist, and that the antinociceptive action caused by morphine is 
potentialized with low-dose acetaminophen and this effect is dependent upon an in-
teraction between opioidergic and serotoninergic systems.14,15 In addition, the fact 
that naloxone blocks the enhancement of antinociceptive action was associated with 
acetaminophen using receptors identical to that of naloxone.14–16 Naloxone has been 
reported to antagonize the antinociceptive actions of some nonopioid drugs (such as 
acetaminophen) in certain experiments, and observed to have certain activities as a 
GABA antagonist.17,18
In the scope of the present study, opioid receptors were blocked with naloxone and 
then acetaminophen was administered at a dose of 300 mg/kg. The antinociceptive 
action of acetaminophen was not antagonized by pretreatment with naloxone. Sandrini 
et al15 administered morphine (2, 3, or 5 mg/kg SC) and acetaminophen (50 or 
100 mg/kg IP) to male Wistar rats that were pretreated with naloxone (1 mg/kg IP) 
in their study. As a result, they found that the enhancement in antinociceptive action 
made by acetaminophen was blocked by naloxone. However, this reduction could be 
in association with the decrease of antinociceptive action of morphine via opioid- 
receptor blockage. Pini et al18 administered naloxone 30 minutes prior to the admin-
istration of acetaminophen to assess whether or not the antinociceptive action was 
antagonized in rats. However, in the present study, naloxone was administered 5 min-
utes before the administration of acetaminophen to avoid the possible reduction of the 
receptor blockage after 60 minutes. Throughout this study, in which the antagoniza-
tion of the antinociceptive action was assessed at 30 minutes after acetaminophen 
administration, the antinociceptive action generated by acetaminophen was not an-
tagonized by naloxone at any measurement point. These results suggest that the 
mechanism of action for acetaminophen does not involve opioid receptors.
Gear et al,19 in a double-blind, placebo-controlled study, reported that flumazenil 
enhances the analgesic action of postoperative morphine in patients with dental pain 
who are administered preoperative benzodiazepine and that benzodiazepines antago-
nize the opioid analgesia via GABAA receptors. According to the study performed 
by Holtman et al,20 flumazenil–morphine interaction on analgesia was tested after 
intraperitoneal and intrathecal routes of administration in female rats; IP flumazenil 
(0.5 mg/kg) alone did not produce analgesia and analgesia was enhanced by the con-
current administration of IP flumazenil (0.5 mg/kg) with morphine (2 mg/kg). In 
contrast, analgesic action was not enhanced by morphine administered intrathecally. 
These data suggest that morphine enhances analgesic efficacy by benzodiazepine re-
ceptors at sites other than the spinal cord.
Studies indicate that GABA receptors are involved in spinal nociception.19,20 By 
performing the present study we take into consideration the possibility that the mani-
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festation of the interaction of acetaminophen with GABA receptors, which have been 
proven to have significant effects on the transmission of nociception and its regulation,21 
will be a new explanation for the mechanism of antinociceptive effects of acetamino-
phen. Therefore, we have aimed at achieving a competitive antagonism at the receptor 
level by administering flumazenil acting as GABA receptor antagonist, prior to the 
administration of acetaminophen. This study found that the antinociceptive action of 
acetaminophen in the AF group was antagonized by flumazenil. The antagonism of 
the antinociceptive action was induced in the 30th minute following acetaminophen 
administration and it was maintained up to the 90th minute at all measurement 
points. There was not any statistically significant difference observed at any of the 
intermediate measurement points in the AF group. 
This was a small experimental study in a pain model in rats; therefore, the results 
cannot be extrapolated to clinical use. Further studies are needed to evaluate the in-
teraction between acetaminophen and flumazenil activation pathways.
COnClusIOn
Flumazenil significantly antagonized the analgesic effect exerted by acetaminophen, 
but naloxone had no significant effect on acetaminophen’s antinociceptive action in 
this pain model in rats. 
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